Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Clinical Application of $^{18}F-FDG$ PET in Malignant Melanoma

악성 흑색종에서 $^{18}F-FDG$ PET의 임상 이용

  • Yoon, Joon-Kee (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine)
  • 윤준기 (아주대학교 의과대학 핵의학교실)
  • Published : 2008.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

$^{18}F-FDG$ PET showed a high sensitivity and specificity in the initial staging of malignant melanoma, and it also predicted the prognosis correctly. In addition, it had a higher sensitivity and specificity in the detection of recurrence and restaging than conventional imaging modalities. Meanwhile, there's less clinical evidence to support the use of $^{18}F-FDG$ PET in the response evaluation for chemotherapy and the diagnosis/differential diagnosis of malignant melanoma.

Keywords